Search research articles
Contact Us
Filters
Showing results (1-10 of 179) with videos related to
Page
of 18
Sort By:
La Revue Du Praticien
|
March 8, 2022
[Contribution of neoadjuvant chemotherapy in rectal cancer]
Jean-Baptiste Bachet
Bulletin Du Cancer
|
August 7, 2022
[Advanced GIST: Which treatments in 2022?]
Léo Mas, Jean-Baptiste Bachet
La Revue Du Praticien
|
January 5, 2011
[Colorectal cancer: what progress can we anticipate in the next few years?]
Jean-Baptiste Bachet, Philippe Rougier
The Application of Clinical Genetics
|
June 19, 2013
Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors
Jean-Baptiste Bachet, Jean-François Emile
La Revue Du Praticien
|
May 5, 2009
[Colon and rectal tumours]
Jean-Baptiste Bachet, Gilles Lesur, Philippe Rougier
Current Opinion in Oncology
|
June 17, 2020
Adjuvant chemotherapy in pancreatic cancer: state of the art and future perspectives
Léo Mas, Lilian Schwarz, Jean-Baptiste Bachet
Cancers
|
November 12, 2013
Treatment of pancreatic cancer: what can we really predict today?
Jean-Baptiste Bachet, Raphael Marechal, Jean-Luc Van Laethem
Bulletin Du Cancer
|
June 18, 2021
[Neoadjuvant treatment for rectal cancer]
Jean-Baptiste Bachet, Stéphane Benoist, Léo Mas, et al.
Bulletin Du Cancer
|
July 9, 2013
[What is the contribution of tumor response in colorectal cancer?]
Jean-Baptiste Bachet, Xavier Paoletti, Laure Fournier, et al.
British Journal of Cancer
|
April 29, 2016
Reply to the comment on 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
Simon Pernot, Jean-Baptiste Bachet, Alix Portal, et al.
Page
of 18
Search research articles
Search
Showing results (1-10 of 179) with videos related to
Sort By:
Page
of 18
La Revue Du Praticien
|
March 8, 2022
[Contribution of neoadjuvant chemotherapy in rectal cancer]
Jean-Baptiste Bachet
Bulletin Du Cancer
|
August 7, 2022
[Advanced GIST: Which treatments in 2022?]
Léo Mas, Jean-Baptiste Bachet
La Revue Du Praticien
|
January 5, 2011
[Colorectal cancer: what progress can we anticipate in the next few years?]
Jean-Baptiste Bachet, Philippe Rougier
The Application of Clinical Genetics
|
June 19, 2013
Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors
Jean-Baptiste Bachet, Jean-François Emile
La Revue Du Praticien
|
May 5, 2009
[Colon and rectal tumours]
Jean-Baptiste Bachet, Gilles Lesur, Philippe Rougier
Current Opinion in Oncology
|
June 17, 2020
Adjuvant chemotherapy in pancreatic cancer: state of the art and future perspectives
Léo Mas, Lilian Schwarz, Jean-Baptiste Bachet
Cancers
|
November 12, 2013
Treatment of pancreatic cancer: what can we really predict today?
Jean-Baptiste Bachet, Raphael Marechal, Jean-Luc Van Laethem
Bulletin Du Cancer
|
June 18, 2021
[Neoadjuvant treatment for rectal cancer]
Jean-Baptiste Bachet, Stéphane Benoist, Léo Mas, et al.
Bulletin Du Cancer
|
July 9, 2013
[What is the contribution of tumor response in colorectal cancer?]
Jean-Baptiste Bachet, Xavier Paoletti, Laure Fournier, et al.
British Journal of Cancer
|
April 29, 2016
Reply to the comment on 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
Simon Pernot, Jean-Baptiste Bachet, Alix Portal, et al.
Page
of 18